The biological and clinical impact of deletions before and after large chromosomal gains in multiple myeloma
Anthony Cirrincione(University of Miami), Francesco Maura(Memorial Sloan Kettering Cancer Center), Kylee Maclachlan(Memorial Sloan Kettering Cancer Center), Saad Z. Usmani(Memorial Sloan Kettering Cancer Center), Philipp Reichert(Heidelberg University), Katja Weisel(Universität Hamburg), Ahmet Doǧan(Memorial Sloan Kettering Cancer Center), Stefanie Huhn(Heidelberg University), Dylan Gagler(NYU Langone Health), Alexander M. Lesokhin(Memorial Sloan Kettering Cancer Center), Alexandra M. Poos(German Cancer Research Center), Faith E. Davies(NYU Langone Health), Monika Chojnacka(University of Miami), Marc-Andrea Bärtsch(German Cancer Research Center), Bachisio Ziccheddu(University of Miami Health System), Niels Weinhold(German Cancer Research Center), Hartmut Goldschmidt(Heidelberg University), Patrick Blaney(NYU Langone Health), Neha Korde(United States Fish and Wildlife Service), Karsten Rippe(German Cancer Research Center), Marcella Kaddoura(University of Miami Health System), Marc S. Raab(Unknown), Ola Landgren(University of Miami Health System), Roland Fenk(Beth Israel Deaconess Medical Center), Gareth J. Morgan(Hywel Dda University Health Board), K. Elias(Heidelberg University), Benjamin Diamond(Memorial Sloan Kettering Cancer Center), Yanming Zhang(Memorial Sloan Kettering Cancer Center), Lukas John(University of Hohenheim)
Cited by 16
Related Papers
Nivolumab plus Ipilimumab in Advanced Melanoma
|New England Journal of Medicine|2013|4.2k
The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission report
|The Lancet|2019|3.1k
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k